Pregnancy outcome in long-term survivors of childhood cancer

Medical and Pediatric Oncology

Volumn 33, Issue 1, 1999, Pages 29-33

  Blatt, Julie ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Childhood cancer; Long term survivors; Pregnancy outcome

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; BLEOMYCIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; MERCAPTOPURINE; METHOTREXATE; TIOGUANINE; VINBLASTINE; VINCRISTINE;

CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILDHOOD CANCER; CONFERENCE PAPER; CONGENITAL MALFORMATION; DISEASE ASSOCIATION; FEMALE; HODGKIN DISEASE; HUMAN; LOW BIRTH WEIGHT; MALE; NEPHROBLASTOMA; NEWBORN DEATH; NEWBORN DISEASE; PREGNANCY COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SPONTANEOUS ABORTION; SURVIVAL TIME;

EID: 0032983586     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199907)33:1<29::AID-MPO6>3.0.CO;2-2     Document Type: Conference Paper

References (32)

1. Bleyer WA. The impact of childhood cancer on the United States and the world. Cancer 1990;40:355-367.
2. Blatt J. Pregnancy outcome following anticancer therapy. In: Bern MM, Frigoletto FD, editors. Hematologic disorders in maternal-fetal medicine. New York: Wiley-Liss, Inc., 1990, p 569-577.
3. Li FP, Gimbrere K, Gelber RD, et al. Outcome of pregnancy in survivors of Wilms' tumor. JAMA 1987;257:216-219.
4. Byrne J, Mulvihill JJ, Connelly RR, et al. Reproductive problems and birth defects in survivors of Wilms' tumor and their relatives. Med Pediatr Oncol 1988;16:233-240.
5. Holmes GE, Holmes FF. Pregnancy outcome of patients treated for Hodgkin's disease. A controlled study. Cancer 1978;41:1317-1322.
6. McKeen EA, Mulvihill JJ, Rosner F, Zarrabi MH. Pregnancy outcome in Hodgkin's disease. Lancet 1979;ii:590.
7. Green DM, Hall B. Pregnancy outcome following treatment during childhood or adolescence for Hodgkin's disease. Pediatr Hematol Oncol 1988;5:269-277.
8. Horning SJ, Hoppe RT, Kaplan HS, Rosenberg SA. Female reproductive potential after treatment of Hodgkin's disease. N Engl J Med 1981;304:1377-1381.
9. Li FP, Fine W, Jaffe N, Holmes GE, Holmes FF. Offspring of patients treated for cancer in childhood. JNCI 1979;62:1193-1197.
10. Green DM, Hall B, Zevon MA. Pregnancy outcome after treatment for acute lymphoblastic leukemia during childhood or adolescence. Cancer 1989;64:2335-2339.
11. Moe PJ, Lethinen M, Wegelius R, Friman S, Kreuger A, Berg A. Progeny of survivors of acute lymphocytic leukemia. Acta Paediatr Scand 1979;68:301-303.
12. Marradi P, Schaison G, Alby N, Berger R, Jacquillat C, Boiron M. Les enfants nes de parents leucemiques. A propos de 23 enfants. Nouv Rev Fr Hematol 1982;24:75-80.
13. Nygaard R, Clausen N, Siimes MA, et al. Reproduction following treatment for childhood leukemia: a population-based prospective cohort study of fertility and offspring. Med Pediatr Oncol 1991; 19:459-466.
14. Pajor A, Zimonyi I, Koos R, Lehoczky D, Ambrus C. Pregnancies and offspring in survivors of acute lymphoid leukemia and lymphoma. Eur J Obstet Gynecol Reprod Biol 1991;40:1-5.
15. Bundey S, Evans K. Survivors of neuroblastoma and ganglioneuroma and their families. J Med Genet 1983;19:16-21.
16. Hawkins MM, Smith RA, Curtice LJ. Childhood cancer survivors and their offspring studied through a postal survey of general practitioners: Preliminary results. J R Coll Gen Pract 1988;38: 102-105.
17. Green DM, Zevon MA, Lowrie G, Seigelstein N, Hall B. Congenital anomalies in children of patients who received chemotherapy for cancer in childhood and adolescence. N Engl J Med 1991;325:141-146.
18. Blatt J, Mulvihill JJ, Ziegler JL, Young RC, Poplack DG. Pregnancy outcome following cancer chemotherapy. Am J Med 1980; 69:828-832.
19. Kenny LB, Nicholson HS, Brasseaux C, et al. Birth defects in offspring of adult survivors of childhood acute lymphoblastic leukemia. A Childrens Cancer Group/ National Institutes of Health report. Cancer 1996;78:169-176.
20. Green DM, Fiorello A, Zevon MA, Hall B, Seigelstein N. Birth defects and childhood cancer in offspring of survivors of childhood cancer. Arch Pediatr Adolesc Med 1997;151:379-383.
21. Dodds L, Marrett LD, Tomkins DJ, Green B, Sherman G. Case-control study of congenital anomalies in children of cancer patients. Br Med J 1993;307:164-168.
22. Byrne J, Rasmussen SA, Steinhorn SC, et al. Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet 1998;62:45-52.
23. Matheson D, Brusick D, Carrano R. Comparison of the relative mutagenic activity for eight antineoplastic drugs in the Ames Salmonella/microsome and TK+/-mouse lymphoma assays. Drug Chem Toxicol 1978;1:277-304.
24. Benedict WF, Baker MS, Haroun L, Choi E, Ames BN. Mutagenicity of cancer chemotherapeutic agents in the Salmonella/ microsome test. Cancer Res 1977;37:2209-13.
25. Mulvihill JJ, Myers MH, Connely RR, et al. Cancer in offspring of long-term survivors of childhood and adolescent cancer. Lancet 1987;ii:813-817.
26. Hawkins MM, Draper GJ, Smith RA. Cancer among 1,348 offspring of survivors of childhood cancer. Int J Cancer 1989;43: 975-978.
27. Hawkins MM, Draper GJ, Winter DL. Cancer in the offspring of survivors of childhood leukaemia and non-Hodgkin's lymphomas. Br J Cancer 1995;71:1335-1339.
28. Sankila R, Olsen JH, Anderson H, et al. Risk of cancer among offspring of childhood cancer survivors. N Engl J Med 1998;338: 1339-1344.
29. Rubin CM, Robison LL, Nesbit ME, Arthur DL. Cytogenetic study of long-term survivors of childhood acute lymphoblastic leukemia: a follow-up report. Med Pediatr Oncol 1986;14:295-299.
30. Hewitt M, Mott MG. The assessment of in vivo somatic mutations in survivors of childhood malignancy. Br J Cancer 1992;66:143-147.
31. Mott MG, Boyse J, Hewitt M, Radford M. Do mutations at the glycophorin A locus in patients treated for childhood Hodgkin's disease predict secondary leukaemia? Lancet 1994;343:828-829.
32. Hirota H, Kubota M, Adachi S, et al. Somatic mutations at T-cell antigen receptor and glycophorin A loci in pediatric leukemia patients following chemotherapy: comparison with HPRT locus mutation. Mutat Res DNA Repair 1994;315:95-103.